News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Misty Dawn Shields: Outstanding faculty discussions on lung cancer at Texas Lung Cancer Conference 2025
Misty Dawn Shields/X
Apr 13, 2025, 15:47

Misty Dawn Shields: Outstanding faculty discussions on lung cancer at Texas Lung Cancer Conference 2025

Misty Dawn Shields, Assistant Professor at Indiana University School of Medicine, shared a post on X:

“Day 1 of Texas Lung Cancer Conference 2025 at Austin City Limits is underway!

Outstanding faculty discussion on who and when to intensify therapy for patients who have EGFR-altered lung cancer:

  • Brain metastases?
  • Liver metastases?
  • EGFR L858R? P53?
  • Does age matter?”

Misty Dawn Shields: Outstanding faculty discussions on lung cancer at Texas Lung Cancer Conference 2025

More posts featuring Misty Dawn Shields.

cancer Misty Dawn Shields OncoDaily Oncology Texas Lung Cancer Conference 2025 TexasLung25
Special Coverage
Science
Apr 14, 2025, 12:55
Jame Abraham: Educational Video as an Alternative to Pretest In-Person Genetic Counselling in Candidates for Cancer Genetic Testing
Cancer Types
Apr 14, 2025, 12:52
Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates
Blog
Apr 14, 2025, 12:44
E. Shyam P. Reddy: To grow, cancer tumors must hijack the immune system for their needs
Blog
Apr 14, 2025, 12:43
Mel Mann: Never found a donor and I still became HISTORY
Blog
Apr 14, 2025, 12:42
Anirban Maitra: The lineup for the summer 2025 Gordon Research Conferences on Pancreatic Diseases
Blog
Apr 14, 2025, 12:25
Yazan Madanat: Novel investigational therapies in lower-risk MDS
Dialogues
Apr 14, 2025, 12:23
Cancer Through My Eyes – Episode 9: Charles J Milrod
Blog
Apr 14, 2025, 12:16
Farina Arreguin: Sharing pediatric oncology experience in the management of germ cell tumors at AYAS
Blog
Apr 14, 2025, 12:16
The best and brightest cancer researchers were funded with $12M+ in 2024 - Conquer Cancer, the ASCO Foundation
Blog
Apr 14, 2025, 12:14
Amol Akhade: Important Sessions to Watch at ESMO Breast 2025 in Munich
Drugs
Apr 14, 2025, 11:48
Cathy Eng: Apixaban for the primary endpoint of cancer-related recurrent thrombosis
Blog
Apr 14, 2025, 11:40
Kim Stanbery: Celebrating 50 Years of Excellence in Oncology Nursing